Skip to content
MarketHOT
中文
← Latest news

6-K - Nano-X Imaging Ltd. (0001795251) (Filer)

SEC · EDGAR 财务披露 · October 16, 2026 at 4:10 PM ET

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of October 2026

Commission File Number: 001-39461

NANO-X IMAGING LTD

(Translation of registrant’s name into English)

Ofer Tech Park

94 Shlomo Shmeltzer Road

Petach Tikva

Israel 4970602

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒       Form 40-F ☐

CONTENTS

Preliminary Quarterly Results

On October 16, 2026, NANO-X IMAGING LTD. (the “Company”) issued a press release providing a brief business update and furnishing certain preliminary unaudited financial data for the Company’s third quarter ended September 30, 2026. A copy of that press release is attached to this Report of Foreign Private Issuer on Form 6-K (this “Form 6-K”) as Exhibit 99.1.

Exhibits

Exhibit No.   Exhibit
99.1   Press release, dated October 16, 2026, issued by the Company, providing a brief business update and reporting certain preliminary unaudited financial data for the Company’s third quarter ended September 30, 2026

Incorporation by Reference

The contents of this Form 6-K, including Exhibit 99.1 hereto, are hereby incorporated by reference into the Company’s shelf registration statement on Form F-3 (File No. 333-294302), initially filed by the Company with the U.S. Securities and Exchange Commission (the “SEC”) on March 13, 2026 and declared effective by the SEC on March 30, 2026 (the “Form F-3”), including the prospectus supplements, dated July 23, 2026 and August 5, 2026, filed by the Company with the SEC pursuant to Rule 424(b)(5) under the Securities Act of 1933, as amended, on July 24, 2026 and August 7, 2026, respectively, which supplement the prospectus forming a part of the Form F-3.

1

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

  NANO-X IMAGING LTD
     
  By: /s/ Erez Meltzer
  Name:  Erez Meltzer
  Title: Chief Executive Officer and Acting Chairman of the Board
     
  Date: October 16, 2026

2

View source ↗ · 中文页面